SEARCH

SEARCH BY CITATION

References

  • 1
    Ross CN, Gaskin G, Gregor-MacGregor S et al. Renal transplantation following immunoadsorption in highly sensitized recipients. Transplantation 1993; 55: 785789.
  • 2
    Glotz D, Haymann J-P, Sansonetti N et al. Suppression of HLA-specific alloantibodies by high-dose intravenous immunoglobulins (IVIg). Transplantation 1993; 56: 335337.
  • 3
    Tyan DB, Li VA, Czer L, Trento A, Jordan SC. Intravenous immunoglobulin suppression of HLA alloantibody in highly sensitized transplant candidates and transplantation with a histoincompatible organ. Transplantation 1994; 57: 553562.
  • 4
    Alarabi A, Backman U, Wikstrom B, Sjoberg O, Tufeson G. Pretransplantation plasmapheresis in HLA-sensitized patients: Five years experience. Transplant Proc 1995; 27: 3448.
  • 5
    Higgins RM, Bevan DJ, Vaughan RW et al. 5-year follow-up of patients successfully transplanted after immunoadsorption to remove anti-HLA antibodies. Nephron 1996; 74: 5357.
  • 6
    Sonnenday CJ, Warren DS, Cooper M et al. Plasmapheresis, CMV hyperimmune globulin, and anti-CD20 allow ABO-incompatible renal transplantation without splenectomy. Am J Transplant 2004; 4: 13151322.
  • 7
    Montgomery RA, Zachary AA, Racusen LC et al. Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients. Transplantation 2000; 70: 887895.
  • 8
    Zachary AA, Montgomery RA, Ratner LE et al. Specific and durable elimination of antibody to donor HLA antigens in renal-transplant patients. Transplantation 2003; 76: 15191525.
  • 9
    Bohmig GA, Regele H, Exner M et al. C4d-positive acute humoral rejection: Effective treatment by immunoadsorption. J Am Soc Nephrol 2001; 12: 24822489.
  • 10
    Jordan SC, Quartel AW, Czer LSC et al. Posttransplant therapy using high-dose human immunoglobulin (intravenous gammaglobulin) to control acute humoral rejection in renal and cardiac allograft recipients and potential mechanism of action. Transplantation 1998; 66: 800805.
  • 11
    Lederer SR, Kluth-Pepper B, Schneeberger H, Albert E, Land W, Feucht HE. Impact of humoral alloreactivity early after transplantation on the long-term survival of renal allografts. Kidney Int 2001; 59: 334341.
  • 12
    Mauiyyedi S, Della Pelle P, Saidman S et al. Chronic humoral rejection: Identification of antibody-mediated chronic allograft rejection by C4d deposits in peritubular capillaries. J Am Soc Nephrol 2001; 12: 574582.
  • 13
    Regele H, Bohmig GA, Habicht A, Gollowitzer D, Schillinger M, Rockenschaub S. Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: A contribution of humoral immunity to chronic allograft rejection. J Am Soc Nephrol 2002; 13: 23712380.
  • 14
    Trpkov K, Campbell P, Pazderka F, Cockfield S, Solez K, Halloran PF. Pathologic features of acute renal allograft rejection associated with donor-specific antibody. Transplantation 1996; 61: 15861592.
  • 15
    Lederer SR, Schneeberger H, Albert E et al. Early renal graft dysfunction. The role of preformed antibodies to DR-typed lymphoblastoid cell lines. Transplantation 1996; 61: 313319.
  • 16
    Collins AB, Schneeberger EE, Pascual M et al. Complement activation in acute humoral renal allograft rejection: Diagnostic significance of C4d deposits in peritubular capillaries. J Am Soc Nephrol 1999; 10: 22082214.
  • 17
    Mauiyyedi S, Crespo M, Collins AB et al. Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classification. J Am Soc Nephrol 2002; 13: 779787.
  • 18
    Herzenberg AM, Gill JS, Djurdjev O, Magil AB. C4d deposition in acute rejection: An independent long-term prognostic factor. J Am Soc Nephrol 2002; 13: 234241.
  • 19
    Bohmig GA, Exner M, Habicht A et al. Capillary C4d deposition in kidney allografts: A specific marker of alloantibody-dependent graft injury. J Am Soc Nephrol 2002; 13: 10911099.
  • 20
    Racusen LC, Colvin RB, Solez K et al. Antibody-mediated rejection criteria—an addition to the Banff '97 classification of renal allograft rejection. Am J Transplant 2003; 3: 17.
  • 21
    Fidler ME, Gloor JM, Lager DJ et al. Histologic findings of antibody-mediated rejection in ABO blood-group-incompatible living-donor kidney transplantation. Am J Transplant 2004; 4: 101107.
  • 22
    Onitsuka S, Yamaguchi Y, Tanabe K, Takahashi K, Toma H. Peritubular capillary depostion of C4d complement fragment in ABO-incompatible renal transplantation with humoral rejection. Clin Transplant 1999; 13 (Suppl 1): 3337.
  • 23
    Kato M, Morozumi K, Takeuchi O et al. Complement fragment C4d deposition in peritubular capillaries in acute humoral rejection after ABO blood group-incompatible human kidney transplantation. Transplantation 2003; 75: 663665.
  • 24
    Platt JL. C4d and the fate of organ transplants. J Am Soc Nephrol 2002; 13: 24172419.
  • 25
    Chopek MW, Simmons RL, Platt JL. ABO-incompatible renal transplantation: Initial immunopathologic evaluation. Transplant Proc 1987; 19: 45534557.
  • 26
    Park WD, Grande JP, Ninova D et al. Accommodation in ABO-incompatible kidney allografts, a novel mechanism of self-protection against antibody-mediated injury. Am J Transplant 2003; 3: 952960.
  • 27
    Platt JL, Vercellotti GM, Dalmasso AP et al. Transplantation of discordant xenografts: A review of progress. Immunol Today 1990; 11: 450456.
  • 28
    Sund S, Hovig T, Reisaeter AV, Scott H, Bentdal O, Mollnes TE. Complement activation in early protocol kidney graft biopsies after living-donor transplantation. Transplantation 2003; 75: 12041213.
  • 29
    Kuypers DRJ, Lerut E, Evenepoel P, Maes B, Vanrenterghem Y, Van Damme B. C3D deposition in peritubular capillaries indicates a variant of acute renal allograft rejection characterized by a worse clinical outcome. Transplantation 2003; 76: 102108.
  • 30
    Haas M, Ratner LE, Montgomery RA. C4D staining of perioperative renal transplant biopsies. Transplantation 2002; 74: 711717.
  • 31
    Thurman JM, Lucia MS, Ljubanovic D, Holers VM. Acute tubular necrosis is characterized by activation of the alternative pathway of complement. Kidney Int 2005; 67: 524530.
  • 32
    Kanetsuna Y, Yamaguchi Y, Horita S, Tanabe K, Toma H. C4d and/or immunoglobulins deposition in peritubular capillaries in perioperative graft biopsies in ABO-incompatible renal transplantation. Clin Transplant 2004; 18 (Suppl 11): 1317.
  • 33
    Williams JM, Holzknecht ZE, Plummer TB, Lin SS, Brunn GJ, Platt JL. Acute vascular rejection and accommodation: Divergent outcomes of the humoral response to organ transplantation. Transplantation 2004; 78: 14711478.
  • 34
    Baldwin WM III, Kasper EK, Zachary AA, Wasowska BA, Rodriguez ER. Beyond C4d: Other complement-related diagnostic approaches to antibody-mediated rejection. Am J Transplant 2004; 4: 311318.
  • 35
    Takemoto SK, Zeevi A, Feng S et al. National conference to assess antibody-mediated rejection in solid organ transplantation. Am J Transplant 2004; 4: 10331041.
  • 36
    Koo DDH, Roberts ISD, Quiroga I et al. C4d deposition in early renal allograft protocol biopsies. Transplantation 2004; 78: 398403.
  • 37
    Mengel M, Bogers J, Bosmans J-L et al. Incidence of C4d stain in protocol biopsies from renal allografts: Results from a multicenter trial. Am J Transplant 2005; 5: 10501056.